ecrin-mdr-crcClinical2014metastatic colorectal cancerMetastatic Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2654532Japan12ECRIN MDRRecruitingfalseA phase II trial of oxaliplatin, capecitabine, irinotecan (XELOXIRI) and bevacizumab as first-line therapy for patients with metastatic colorectal cancerInterventions: irinotecan, oxaliplatin, capecitabine, bevacizumab Primary outcome(s): Progression-free survival Study Design: Single arm Non-randomized2014-12-152654532JPRN-UMIN000039783